These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 10485472

  • 1. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function.
    Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW.
    Cancer Res; 1999 Sep 01; 59(17):4276-84. PubMed ID: 10485472
    [Abstract] [Full Text] [Related]

  • 2. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM.
    Clin Cancer Res; 2006 Jul 01; 12(13):4062-71. PubMed ID: 16818706
    [Abstract] [Full Text] [Related]

  • 3. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.
    Kuang SQ, Liao L, Wang S, Medina D, O'Malley BW, Xu J.
    Cancer Res; 2005 Sep 01; 65(17):7993-8002. PubMed ID: 16140972
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
    Crowley MR, Frost A, Chen DT, Baffi MO, Nicola T, Serra R.
    Differentiation; 2006 Feb 01; 74(1):40-52. PubMed ID: 16466399
    [Abstract] [Full Text] [Related]

  • 5. Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis.
    Fang Z, Yang S, Lydon JP, DeMayo F, Tamura M, Gurates B, Bulun SE.
    Fertil Steril; 2004 Sep 01; 82(3):673-8. PubMed ID: 15374713
    [Abstract] [Full Text] [Related]

  • 6. Luteinizing hormone secretion from wild-type and progesterone receptor knockout mouse anterior pituitary cells.
    Turgeon JL, Waring DW.
    Endocrinology; 2001 Jul 01; 142(7):3108-15. PubMed ID: 11416033
    [Abstract] [Full Text] [Related]

  • 7. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene.
    Chappell PE, Lydon JP, Conneely OM, O'Malley BW, Levine JE.
    Endocrinology; 1997 Oct 01; 138(10):4147-52. PubMed ID: 9322923
    [Abstract] [Full Text] [Related]

  • 8. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
    Cheung SY, Yuen MT, Choi HL, Cheng HK, Huang Y, Chen S, Chan FL.
    Int J Oncol; 2003 Jun 01; 22(6):1383-95. PubMed ID: 12739009
    [Abstract] [Full Text] [Related]

  • 9. PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.
    Nicol CJ, Yoon M, Ward JM, Yamashita M, Fukamachi K, Peters JM, Gonzalez FJ.
    Carcinogenesis; 2004 Sep 01; 25(9):1747-55. PubMed ID: 15073042
    [Abstract] [Full Text] [Related]

  • 10. Revealing progesterone's role in uterine and mammary gland biology: insights from the mouse.
    Fernandez-Valdivia R, Mukherjee A, Mulac-Jericevic B, Conneely OM, DeMayo FJ, Amato P, Lydon JP.
    Semin Reprod Med; 2005 Feb 01; 23(1):22-37. PubMed ID: 15714387
    [Abstract] [Full Text] [Related]

  • 11. Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro.
    Chatterton RT, Lydon JP, Mehta RG, Mateo ET, Pletz A, Jordan VC.
    Cancer Lett; 2002 Dec 15; 188(1-2):47-52. PubMed ID: 12406547
    [Abstract] [Full Text] [Related]

  • 12. Anxiolytic activity of progesterone in progesterone receptor knockout mice.
    Reddy DS, O'Malley BW, Rogawski MA.
    Neuropharmacology; 2005 Jan 15; 48(1):14-24. PubMed ID: 15617723
    [Abstract] [Full Text] [Related]

  • 13. Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia.
    Medina D, Kittrell F.
    J Cell Sci; 2005 Jan 01; 118(Pt 1):123-7. PubMed ID: 15585572
    [Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1995 May 01; 429():1-286. PubMed ID: 12616302
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY, Kimler BF, Fabian CJ, Petroff BK.
    Carcinogenesis; 2007 Jan 01; 28(1):130-5. PubMed ID: 16891317
    [Abstract] [Full Text] [Related]

  • 16. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M, Akahane T, Buck T, Yoshiji H, Gomez DE, Schoeffner DJ, Okajima E, Harris SR, Bunce OR, Thorgeirsson SS, Thorgeirsson UP.
    Carcinogenesis; 2004 Sep 01; 25(9):1735-46. PubMed ID: 15166086
    [Abstract] [Full Text] [Related]

  • 17. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
    Sung YM, He G, Fischer SM.
    Cancer Res; 2005 Oct 15; 65(20):9304-11. PubMed ID: 16230392
    [Abstract] [Full Text] [Related]

  • 18. Dietary genistein increased DMBA-induced mammary adenocarcinoma in wild-type, but not ER alpha KO, mice.
    Day JK, Besch-Williford C, McMann TR, Hufford MG, Lubahn DB, MacDonald RS.
    Nutr Cancer; 2001 Oct 15; 39(2):226-32. PubMed ID: 11759285
    [Abstract] [Full Text] [Related]

  • 19. Effects of isoproterenol on mammary gland tumors induced by N-nitroso-N-methylurea and salivary gland tumors induced by 7,12-dimethylbenz[a]anthracene.
    Barka T.
    J Natl Cancer Inst; 1982 Nov 15; 69(5):1115-20. PubMed ID: 6813551
    [Abstract] [Full Text] [Related]

  • 20. The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice.
    Tomblyn S, Langenheim JF, Jacquemart IC, Holle E, Chen WY.
    Int J Oncol; 2005 Nov 15; 27(5):1381-9. PubMed ID: 16211235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.